Mitapivat improves ineffective erythropoiesis and iron overload in adult patients with pyruvate kinase deficiencyEduard J. van Beers, Kevin H.M. Kuo, Vanessa Beynon et al.|Blood Advances|2024Cited by 10
Long-Term Improvements in Patient-Reported Outcomes in Patients with Pyruvate Kinase Deficiency Treated with MitapivatKevin H.M. Kuo, Hanny Al‐Samkari, Rachael F. Grace et al.|Blood|2022Cited by 4
Clinically meaningful improvements in patient‐reported outcomes in mitapivat‐treated patients with pyruvate kinase deficiencyKevin H.M. Kuo, Hanny Al‐Samkari, Rachael F. Grace et al.|American Journal of Hematology|2024Cited by 2
P1497: MITAPIVAT IMPROVES IRON OVERLOAD IN PATIENTS WITH PYRUVATE KINASE DEFICIENCY WHO ARE REGULARLY TRANSFUSEDEduard J. van Beers, Kevin H.M. Kuo, Hanny Al‐Samkari et al.|HemaSphere|2023Cited by 1